Clinical Trials Directory

Trials / Completed

CompletedNCT06562296

Study Evaluating Several CAMPs in Nonhealing Diabetic Foot and Venous Leg Ulcers

Multicenter, Prospective, Randomized Controlled Matriarch Trial Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus SOC Alone of Nonhealing Diabetic Foot and Venous Leg Ulcers

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
292 (actual)
Sponsor
Cellution Biologics · Industry
Sex
All
Age
18 Years – 98 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine how well multiple CAMPs (Cellular, Acellular and Matrix-Like Products) and Standard of Care work when compared to Standard of Care alone in achieving complete closure of diabetic foot and venous leg ulcers.

Detailed description

Chronic wounds affect a significant percentage of patients over their lifetime. For example, diabetic foot ulcers (DFU) are a major health complication that affect up to 15% of individuals with diabetes mellitus over their lifetime. The treatment of chronic wounds is extremely challenging as ulcers such as DFUs and Venous Leg Ulcers (VLUs) may not respond to standard of care (SOC) treatment and frequently become infected. Advanced wound products like CAMPs have become an important strategy in the treatment of these chronic wounds by trapping and binding the patients' own cells to rebuild the dermis layer of the skin to aid in healing. This study will evaluate the clinical utility of Multiple CAMPs in the closure of diabetic foot ulcers and venous leg ulcers in subjects in comparison to Standard of Care treatment.

Conditions

Interventions

TypeNameDescription
OTHERAmnion-Intermediate-ChorionDehydrated human placental multilayer allograft from derived donated human tissue. AIC contains amnion and chorion layers as well as basement membrane and trophoblast.
OTHERAmnion-Chorion-AmnionDehydrated human placental trilayer allograft derived from donated human tissue.
PROCEDUREStandard of CareStandard of care is to establish a clean, healthy wound bed and optimize the wound environment to have the best chance of healing the wound. This is achieved through wound cleansing, debridement, offloading and moisture balance.

Timeline

Start date
2024-10-14
Primary completion
2025-06-11
Completion
2026-01-16
First posted
2024-08-20
Last updated
2026-04-13

Locations

4 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT06562296. Inclusion in this directory is not an endorsement.